TB vaccines in clinical development
- PMID: 27470538
- DOI: 10.1016/j.tube.2016.05.013
TB vaccines in clinical development
Abstract
The 4th Global Forum on TB Vaccines, convened in Shanghai, China, from 21 - 24 April 2015, brought together a wide and diverse community involved in tuberculosis vaccine research and development to discuss the current status of, and future directions for this critical effort. This paper summarizes the sessions on TB Vaccines in Clinical Development, and Clinical Research: Data and Findings. Summaries of all sessions from the 4th Global Forum are compiled in a special supplement of Tuberculosis. [August 2016, Vol 99, Supp S1, S1-S30].
Keywords: Clinical trial; Immunogenicity; Safety; TB vaccine.
Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.
Similar articles
-
Novel approaches to preclinical research and TB vaccine development.Tuberculosis (Edinb). 2016 Aug;99 Suppl 1:S12-5. doi: 10.1016/j.tube.2016.05.012. Epub 2016 Jun 16. Tuberculosis (Edinb). 2016. PMID: 27452413
-
TB biomarkers, TB correlates and human challenge models: New tools for improving assessment of new TB vaccines.Tuberculosis (Edinb). 2016 Aug;99 Suppl 1:S8-S11. doi: 10.1016/j.tube.2016.05.010. Epub 2016 Jun 16. Tuberculosis (Edinb). 2016. PMID: 27402312
-
Immunopathogenesis of tuberculosis and novel mechanisms of vaccine activity.Tuberculosis (Edinb). 2016 Aug;99 Suppl 1:S3-7. doi: 10.1016/j.tube.2016.05.011. Epub 2016 Jun 16. Tuberculosis (Edinb). 2016. PMID: 27450395
-
Heterologous boost vaccines for bacillus Calmette-Guérin prime immunization against tuberculosis.Expert Rev Vaccines. 2007 Aug;6(4):539-46. doi: 10.1586/14760584.6.4.539. Expert Rev Vaccines. 2007. PMID: 17669008 Review.
-
MTBVAC from discovery to clinical trials in tuberculosis-endemic countries.Expert Rev Vaccines. 2017 Jun;16(6):565-576. doi: 10.1080/14760584.2017.1324303. Epub 2017 May 12. Expert Rev Vaccines. 2017. PMID: 28447476 Review.
Cited by
-
Reasons for optimism in the search for new vaccines for tuberculosis.Epidemiol Infect. 2017 Jul;145(9):1750-1756. doi: 10.1017/S095026881700067X. Epub 2017 Apr 17. Epidemiol Infect. 2017. PMID: 28414012 Free PMC article.
-
bioA mutant of Mycobacterium tuberculosis shows severe growth defect and imparts protection against tuberculosis in guinea pigs.PLoS One. 2017 Jun 28;12(6):e0179513. doi: 10.1371/journal.pone.0179513. eCollection 2017. PLoS One. 2017. PMID: 28658275 Free PMC article.
-
Designing tuberculosis vaccine efficacy trials - lessons from recent studies.Expert Rev Vaccines. 2019 May;18(5):423-432. doi: 10.1080/14760584.2019.1593143. Epub 2019 Mar 20. Expert Rev Vaccines. 2019. PMID: 30892969 Free PMC article.
-
Mycobacterium tuberculosis-specific CD4+ and CD8+ T cells differ in their capacity to recognize infected macrophages.PLoS Pathog. 2018 May 21;14(5):e1007060. doi: 10.1371/journal.ppat.1007060. eCollection 2018 Feb. PLoS Pathog. 2018. PMID: 29782535 Free PMC article.
-
Clinical Significance of M1/M2 Macrophages and Related Cytokines in Patients with Spinal Tuberculosis.Dis Markers. 2020 May 20;2020:2509454. doi: 10.1155/2020/2509454. eCollection 2020. Dis Markers. 2020. PMID: 32566036 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
